A COMPARISON OF POTASSIUM PERCHLORATE, METHYLTHIOURACIL, AND CARBIMAZOLE IN THE TREATMENT OF THYROTOXICOSIS
- 20 February 1960
- journal article
- Published by Elsevier in The Lancet
- Vol. 275 (7121) , 401-404
- https://doi.org/10.1016/s0140-6736(60)90335-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A CLINICAL METHOD OF ASSESSING THE RESULTS OF THERAPY IN THYROTOXICOSISThe Lancet, 1960
- Erfahrungen mit der Perchlorat-Therapie der Hyperthyreosen1Deutsche Medizinische Wochenschrift (1946), 1957
- Antithyroid DrugsPostgraduate Medical Journal, 1957
- Low Toxicity of CarbimazoleBMJ, 1956
- TOXICITY OF THE ANTITHYROID DRUG CARBIMAZOLEJournal of Clinical Endocrinology & Metabolism, 1956
- PRELIMINARY EXPERIENCE IN THE TREATMENT OF HYPERTHYROIDISM WITH POTASSIUM PERCHLORATE*†Journal of Clinical Endocrinology & Metabolism, 1953
- TREATMENT OF THYROTOXICOSIS WITH 'NEO MERCAZOLE' (2-CARBETHOXYTHIO-1-METHYLGLYOXALINE): REPORT OF 120 CASESThe Lancet, 1953
- A COMPARISON OF THE ANTI-THYROID ACTIVITY OF PARA-AMINOBENZOIC ACID AND THIOURACIL COMPOUNDSThe Lancet, 1949
- Lowered Incidence of Sensitization with Sulphonamide CombinationsBMJ, 1948
- THE EFFECT OF THIOURACIL ON THE FORMATION OF THYROXINE AND DIIODOTYROSINE BY THE THYROID GLAND OF THE RAT WITH RADIOACTIVE IODINE AS INDICATOR1Endocrinology, 1944